Hyperforin in St. John's wort drug interactions (Q34494412)

2 August 2017

1 reference

title

Hyperforin in St. John's wort drug interactions (English)

1 reference

2 August 2017

Veronika Butterweck

1 reference

2 August 2017

Hartmut Derendorf

1 reference

2 August 2017

author name string

Rajanikanth Madabushi

series ordinal

1 reference

2 August 2017

Bruno Frank

series ordinal

1 reference

2 August 2017

Bernd Drewelow

series ordinal

1 reference

2 August 2017

publication date

14 February 2006

1 reference

European Journal of Clinical Pharmacology

2 August 2017

published in

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

225-233

1 reference

Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks

2 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-006-0096-0

The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-006-0096-0

Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-006-0096-0

Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study

21 January 2018

1 reference

12 December 2020

Structure and function of P-glycoprotein in normal liver and small intestine

1 reference

12 December 2020

Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding

1 reference

12 December 2020

Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1

1 reference

12 December 2020

The interaction between St John's wort and an oral contraceptive

1 reference

12 December 2020

Potential metabolic interaction between St. John's wort and theophylline

1 reference

12 December 2020

Metabolism of 17 alpha-ethynylestradiol in humans

1 reference

12 December 2020

Pharmacokinetic interactions of drugs with St John's wort

1 reference

12 December 2020

Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction.

1 reference

12 December 2020

Effect of St. John's wort on the pharmacokinetics of theophylline in healthy volunteers

1 reference

12 December 2020

A simple non-invasive procedure for the investigation of cytochrome P-450 IIIA dependent enzymes in humans

1 reference

12 December 2020

Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression

1 reference

12 December 2020

Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers

1 reference

12 December 2020

Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers

1 reference

12 December 2020

Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression.

1 reference

12 December 2020

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar?

1 reference

12 December 2020

Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with Norplant implants

1 reference

12 December 2020

Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin

1 reference

12 December 2020

Drug interactions with St John's wort : mechanisms and clinical implications

1 reference

12 December 2020

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

1 reference

12 December 2020

Human cytochrome P450s: selectivity and measurement in vivo

1 reference

12 December 2020

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*

1 reference

12 December 2020

Hypericum extract LI 160 and fluoxetine in mild to moderate depression: a randomized, placebo-controlled multi-center study in outpatients

1 reference

12 December 2020

Urinary 6-beta-OH-cortisol and paracetamol metabolites as a probe for assessing oxidation and conjugation of chemicals in humans

1 reference

12 December 2020

Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics

1 reference

12 December 2020

Enhanced metabolism of levonorgestrel during phenobarbital treatment and resultant pregnancy

1 reference

12 December 2020

Contraceptive effectiveness: cytochromes and induction

1 reference

12 December 2020

Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures

1 reference

12 December 2020

Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)

1 reference

12 December 2020

Second thoughts about safety of St John's wort

1 reference

12 December 2020

Acute heart transplant rejection due to Saint John's wort

1 reference

12 December 2020

Interaction of St John's wort with conventional drugs: systematic review of clinical trials

1 reference

12 December 2020

St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy

1 reference

12 December 2020

Herbal medications for common ailments in the elderly

1 reference

12 December 2020

Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study

1 reference

12 December 2020

St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4

1 reference

12 December 2020

Hyperforin contributes to the hepatic CYP3A-inducing effect of Hypericum perforatum extract in the mouse

1 reference

12 December 2020

Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.

1 reference

12 December 2020

The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity

1 reference

12 December 2020

Efficacy and tolerability of hypericum extract STW3 in long-term treatment with a once-daily dosage in comparison with sertraline

1 reference

12 December 2020

No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract

1 reference

12 December 2020

Mechanism of action of St John's wort in depression : what is known?

1 reference

12 December 2020

Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment

1 reference

12 December 2020

Comparison of St John's wort and imipramine for treating depression: randomised controlled trial

1 reference

12 December 2020

The role of CYP2C in the in vitro bioactivation of the contraceptive steroid desogestrel.

1 reference

12 December 2020

Clinical trials with hypericum extracts in patients with depression--results, comparisons, conclusions for therapy with antidepressant drugs

1 reference

12 December 2020

St Johns wort increases expression of P-glycoprotein: implications for drug interactions

1 reference

12 December 2020

Interaction of St John's wort with low‐dose oral contraceptive therapy: a randomized controlled trial

1 reference

12 December 2020

St John's Wort: effect on CYP3A4 activity

1 reference

12 December 2020

St John's wort (Hypericum perforatum): drug interactions and clinical outcomes

1 reference

12 December 2020

St. John's wort and depression: efficacy, safety and tolerability-an update

1 reference

12 December 2020

Molecular genetics of the human cytochrome P450 monooxygenase superfamily

1 reference

12 December 2020

In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase

1 reference

12 December 2020

Update: clinically significant cytochrome P-450 drug interactions

1 reference

12 December 2020

Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception

1 reference

12 December 2020

Interactions between herbal medicines and prescribed drugs: a systematic review

1 reference

12 December 2020

Indinavir concentrations and St John's wort.

1 reference

12 December 2020

10.1007/S00228-006-0096-0

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1051236931

0 references

1 reference